Jens Faber

Jens Faber

Professor, emeritus


Publication year:
All
91 - 100 out of 168Page size: 10
Sort by: 1st author
  1. Published

    Metabolic Effects of Empagliflozin in Heart Failure A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)

    Jensen, J., Omar, M., Kistorp, Caroline Michaela Nervil, Tuxen, C., Gustafsson, I., Køber, Lars Valeur, Gustafsson, Finn, Faber, Jens, Forman, Julie Lyng, Møller, J. E. & Schou, Morten, 2021, In: Circulation. 143, 22, p. 2208-2210 3 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  2. Published

    Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial

    Jensen, J., Omar, M., Kistorp, Caroline Michaela Nervil, Poulsen, M. K., Tuxen, C., Gustafsson, I., Køber, Lars Valeur, Gustafsson, Finn, Faber, Jens, Fosbøl, E. L., Bruun, Niels Eske, Brønd, J. C., Forman, Julie Lyng, Videbæk, L., Møller, J. E. & Schou, Morten, 2020, In: American Heart Journal. 228, p. 47-56 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes

    Johansen, M. L., Schou, Morten, Rasmussen, J., Rossignol, P., Holm, M. R., Chabanova, E., Dela, Flemming, Faber, Jens & Kistorp, Caroline Michaela Nervil, 2019, In: Diabetes & Metabolism. 45, 5, p. 429-435

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial)

    Johansen, M. L., Schou, Morten, Rossignol, P., Holm, M. R., Rasmussen, J., Brandt, N., Frandsen, M., Chabanova, E., Dela, Flemming, Faber, Jens & Kistorp, Caroline Michaela Nervil, 2019, In: Diabetes, Obesity and Metabolism. 21, 10, p. 2305-2314 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes

    Johansen, M. L., Ibarrola, J., Fernández-Celis, A., Schou, Morten, Sonne, M. P., Refsgaard Holm, M., Rasmussen, J., Dela, Flemming, Jaisser, F., Faber, Jens, Rossignol, P., Lopez-Andres, N. & Kistorp, Caroline Michaela Nervil, 2021, In: Diabetes. 70, 1, p. 196-203 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effects of empagliflozin on myocardial flow reserve in patients with type 2 diabetes mellitus: The simple trial

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Wiberg, M., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2021, In: Journal of the American Heart Association. 10, 15, e020418.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Wiberg, M., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2019, In: BMJ Open. 9, 11, 8 p., e029098.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2888-2896 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes

    Kistorp, C., Chong, A. Y., Gustafsson, F., Galatius, S., Raymond, I., Faber, J., Lip, G. Y., Hildebrandt, P., Kistorp, C., Chong, A. Y., Gustafsson, F., Galatius, S., Raymond, I., Faber, Jens, Lip, G. Y. H. & Hildebrandt, P., 2008, In: European Journal of Heart Failure. 10, 4, p. 380-7 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

    Kistorp, C., Raymond, I., Pedersen, F., Gustafsson, Finn, Faber, Jens & Hildebrandt, P., 2005, In: J A M A: The Journal of the American Medical Association. 293, 13, p. 1609-16 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...6 7 8 9 10 11 12 13 ...17 Next

ID: 358461459